Pregnancy News and Research

Latest Pregnancy News and Research

Four-year follow-up results from SPRYCEL Phase 3 study in CML-CP presented at ASCO

Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today announced four-year follow-up results from a Phase 3 randomized, open-label, dose-optimization study of SPRYCEL® (dasatinib) in chronic-phase chronic myeloid leukemia (CML-CP) patients resistant or intolerant to Gleevec®* (imatinib mesylate). At four years, for all patients administered SPRYCEL 100 mg once daily, overall survival was 82% (95% CI: 76%-88%) and progression-free survival was 66% (95% CI: 57%-74%).

9 Jun 2010

In the news: Senate and jobs bill; Obama appeals to seniors; States' Medicaid squeeze; Beyond COBRA

Today's headlines highlights President Obama's planned visit to a senior center to tout health reform, while several columns examine insurance issues, what doctors say about electronic medical record goals and military treatment of traumatic brain injuries is investigated.

9 Jun 2010

CMAJ to publish comprehensive new guidelines on immigrant health

CMAJ will publish a ground-breaking series of comprehensive new guidelines on immigrant health (pre-embargo link only) beginning June 7, 2010 . The Canadian Immigrant Health Guidelines, a multi-part series, will assist clinicians, policy makers and immigrants in understanding the diverse needs of immigrants to Canada. Few resources like this exist in the international medical literature.

8 Jun 2010

Columbia completes enrollment in PROCHIEVE 8% Phase III study to reduce preterm birth in short cervix women

Columbia Laboratories, Inc. today announced it completed enrollment in the PREGNANT (PROCHIEVE Extending GestatioN A New Therapy) Study last week. This randomized, double-blind, placebo controlled Phase III clinical study is evaluating the safety and efficacy of PROCHIEVE® 8% (progesterone gel) to reduce the risk of preterm birth in women with a cervical length between 1.0 and 2.0 centimeters as measured by transvaginal ultrasound at mid-pregnancy.

8 Jun 2010

Single semen test for clearance following vasectomy

Having to provide repeated semen samples following a vasectomy could soon be a thing of the past, after 96 per cent of men were given the all-clear based on a single test three months after surgery.

8 Jun 2010

Hardships in childhood and adolescence influence pregnancy outcome: Study

Childhood hardships may be related to future pregnancy outcomes, in part through their association with smoking during pregnancy and adult socioeconomic position, according to a report in the June issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

8 Jun 2010

Evidence-based oral health guidelines for pregnant women

Health care providers now have evidence-based guidelines to emphasize the importance of pregnant women maintaining good oral health care and the safety of providing appropriate treatment during pregnancy as published in the June Journal of the California Dental Association.

8 Jun 2010

Women who quit smoking during pregnancy will prevent infant deaths

If more women quit smoking before they became pregnant, it would save infant lives, concludes a new study from the Centers for Disease Control and Prevention (CDC).

8 Jun 2010

UNFPA, CARE partner to improve health of women and girls

Leaders from UNFPA, United Nations Population Fund, and CARE International announced today at the Women Deliver Conference an agreement to enhance collaboration on maternal health programs in more than 25 countries. This unique collaboration will bring together UNFPA's effective work with national governments and CARE's expertise in engaging local communities.

8 Jun 2010

Gates Foundation to invest $1.5 billion for integrated women's and children's health programs

Melinda Gates today urged global leaders to make women's and children's health a top priority, and announced that the Gates Foundation will invest $1.5 billion over the next five years to support maternal and child health, family planning, and nutrition programs in developing countries.

8 Jun 2010

Researchers present data from Phase II study of lenalidomide in patients with untreated CLL at ASCO

Celgene International Sàrl today announced that researchers presented data from an investigator-initiated Phase II study of lenalidomide (REVLIMID) in untreated patients with chronic lymphocytic leukemia at the annual meeting of the American Society of Clinical Oncology.

8 Jun 2010

30 percent of Aussie mums think it’s OK to drink alcohol while pregnant

A new Australian study has revealed an alarming trend showing one in three pregnant or breastfeeding woman are still drinking alcohol. The Alcohol Education and Rehabilitation Foundation (AERF) feel that in spite of warnings to pregnant women to cut out alcohol completely from their diets, many women are ignoring such warnings.

7 Jun 2010

The Female Health Company granted U.S. Patent for FC2 Female Condom

The Female Health Company today announced that on June 1, 2010, the U.S. Patent office issued patent number U.S. 7,726,316 B1 for its second generation product, the FC2 Female Condom. In addition to the newly issued U.S. patent, Spain, Greece and Turkey recently issued patents on the FC2 Female Condom.

7 Jun 2010

Genentech reports results from Phase III study of Avastin in women with advanced ovarian cancer

Genentech, Inc., a wholly owned member of the Roche Group, today announced results from a Phase III study of Avastin (bevacizumab) that showed women with previously untreated advanced ovarian cancer who received Avastin in combination with chemotherapy, followed by the continuation of Avastin alone, had a 39 percent improvement in the likelihood of living longer without the disease worsening (progression-free survival or PFS) compared to chemotherapy alone.

7 Jun 2010

Millennium reports on data of VELCADE for multiple myeloma from 2010 ASCO oral presentations

Millennium: The Takeda Oncology Company today reported on data from oral presentations of VELCADE® (bortezomib) for Injection based therapy in multiple myeloma presented at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO). These data highlight VELCADE based therapy in both transplant and non-transplant eligible previously untreated multiple myeloma patients, as well as VELCADE used as induction and/or maintenance therapy.

7 Jun 2010

$2M federal grant to double computing power at Southwest Foundation For Biomedical Research

The "computer ranch" at the Southwest Foundation for Biomedical Research (SFBR), one of the world's largest clusters of computers for human gene research, will more than double in size this summer, thanks to a $2 million federal grant that will speed the pace of discovery at the Foundation's AT&T Genomics Computing Center.

5 Jun 2010

Celgene reports initial data from investigator-initiated study of REVLIMID

Celgene International Sàrl today announced that initial data from an investigator-initiated study of REVLIMID (lenalidomide) plus Rituxan (rituximab) in patients with newly diagnosed indolent B-cell non-Hodgkin's lymphoma (NHL) were presented at the annual meeting of the American Society of Clinical Oncology.

5 Jun 2010

Millennium announces data on VELCADE in treatment of patients with amyloidosis

Millennium: The Takeda Oncology Company today announced data examining the use of VELCADE in the treatment of patients with relapsed or refractory light chain (AL) amyloidosis. Amyloidosis is a rare condition in which excessive proteins build up in organs or tissues, such as the heart, kidney or liver. These data were presented at the Annual Meeting of the American Society of Clinical Oncology (ASCO) held in Chicago, Illinois, June 4-8, 2010.

5 Jun 2010

British PM calls for G8, G20 to reduce maternal mortality, announces new health worker training fund

In a Guardian opinion piece, published on Thursday, British Prime Minister David Cameron says G8 and G20 nations should reduce maternal mortality in developing countries and set "'an ambitious target' of saving three million more lives by 2015," the Guardian reports (Watt, 6/3).

5 Jun 2010

Researchers present clinical outcomes of lenalidomide in patients with large B-cell lymphoma

Celgene International Sàrl today announced researchers at the annual meeting of the American Society of Clinical Oncology presented data from an evaluation of lenalidomide (REVLIMID) in patients with diffuse large B-cell lymphoma either with a germinal center B-cell or non-germinal center B-cell phenotype.

5 Jun 2010

Pregnancy News and Research

Latest Pregnancy News and Research

Four-year follow-up results from SPRYCEL Phase 3 study in CML-CP presented at ASCO

In the news: Senate and jobs bill; Obama appeals to seniors; States' Medicaid squeeze; Beyond COBRA

CMAJ to publish comprehensive new guidelines on immigrant health

Columbia completes enrollment in PROCHIEVE 8% Phase III study to reduce preterm birth in short cervix women

Single semen test for clearance following vasectomy

Hardships in childhood and adolescence influence pregnancy outcome: Study

Evidence-based oral health guidelines for pregnant women

Women who quit smoking during pregnancy will prevent infant deaths

UNFPA, CARE partner to improve health of women and girls

Gates Foundation to invest $1.5 billion for integrated women's and children's health programs

Researchers present data from Phase II study of lenalidomide in patients with untreated CLL at ASCO

30 percent of Aussie mums think it’s OK to drink alcohol while pregnant

The Female Health Company granted U.S. Patent for FC2 Female Condom

Genentech reports results from Phase III study of Avastin in women with advanced ovarian cancer

Millennium reports on data of VELCADE for multiple myeloma from 2010 ASCO oral presentations

$2M federal grant to double computing power at Southwest Foundation For Biomedical Research

Celgene reports initial data from investigator-initiated study of REVLIMID

Millennium announces data on VELCADE in treatment of patients with amyloidosis

British PM calls for G8, G20 to reduce maternal mortality, announces new health worker training fund

Researchers present clinical outcomes of lenalidomide in patients with large B-cell lymphoma

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Pregnancy News and Research

Latest Pregnancy News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in